BMC Cancer, 1471-2407

Tidskrift

Fler filtreringsmöjligheter
  1. 2002
  2. Chromosomal aberrations in benign and malignant Bilharzia-associated bladder lesions analyzed by comparative genomic hybridization.

    Imad Elmula, Soili Kytola, Mona Leithy, Mohamed Abdel-Hameed, Nils Mandahl, Atif Elagib, Muntaser Ibrahim, Catharina Larsson & Sverre Heim, 2002, I : BMC Cancer. 2:5

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Predominance of CIN versus MSI in the development of rectal cancer at young age.

    Eva Fernebro, Britta Halvarsson, Bo Baldetorp & Mef Nilbert, 2002, I : BMC Cancer. 2, 1, s. 25-25

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Male gynecomastia and risk for malignant tumours--a cohort study

    H Olsson, A Bladstrom & P Alm, 2002 okt 16, I : BMC Cancer. 2, s. 26

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2003
  6. A protein kinase Cbeta inhibitor attenuates multidrug resistance of neuroblastoma cells.

    Karin Svensson & Christer Larsson, 2003, I : BMC Cancer. 3, 1, s. 10-10

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Relation between the rate of tumour cell proliferation and latency time in radiation associated breast cancer.

    Håkan Olsson, Bo Baldetorp, Mårten Fernö & Roland Perfekt, 2003, I : BMC Cancer. 3, 1, s. 11-11

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Should tumor depth be included in prognostication of soft tissue sarcoma?

    Anders Rydholm & Pelle Gustafson, 2003, I : BMC Cancer. 3, 1, 7.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2004
  10. Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression

    Anna Lagergren, Christina Manetopoulos, Håkan Axelson & Mikael Sigvardsson, 2004, I : BMC Cancer. 4

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2005
  12. Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma.

    Kajsa Ericson Lindquist, Anna Isinger Ekstrand, Björn L Isfoss & Mef Nilbert, 2005, I : BMC Cancer. 5, 1

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2006
  14. CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum

    Anna Isinger Ekstrand, M Bhat, Åke Borg & Mef Nilbert, 2006, I : BMC Cancer. 6, 64.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures

    Natalija Eigeliene, Pirkko Härkönen & Risto Erkkola, 2006, I : BMC Cancer. 6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy

    Jens Engleson, Maria Soller, Ioannis Panagopoulos, A Dahlen, Michael Dictor & Mats Jerkeman, 2006, I : BMC Cancer. 6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. 2008
  18. Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice

    Johanna M. Tuomela, Maija P. Valta, Kalervo Vaananen & Pirkko Härkönen, 2008, I : BMC Cancer. 8

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer

    Bjorn Lindkvist, Dorthe Johansen, Anders Borgström & Jonas Manjer, 2008, I : BMC Cancer. 8, 321.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. K-ras mutations in sinonasal cancers in relation to wood dust exposure

    Jette Bornholdt, Johnni Hansen, Torben Steiniche, Michael Dictor, Annemarie Antonsen, Henrik Wolff, Vivi Schluenssen, Reetta Holmila, Daniele Luce, Ulla Vogel, Kirsti Husgafvel-Pursiainen & Hakan Wallin, 2008, I : BMC Cancer. 8, 53

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer

    Ana Carneiro, Anna Isinger Ekstrand, Anna Karlsson, Janet Johansson, Göran B Jönsson, Pär-Ola Bendahl, Dan Falkenback, Britta Halvarsson & Mef Nilbert, 2008, I : BMC Cancer. 8, 98

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Protein kinase Cepsilon is important for migration of neuroblastoma cells

    Helena Stensman & Christer Larsson, 2008, I : BMC Cancer. 8

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Recurrent and multiple bladder tumors show conserved expression profiles.

    David Lindgren, Sigurdur Gudjonsson, Kowan Ja Jee, Fredrik Liedberg, Sonja Aits, Anna Andersson, Gunilla Chebil, Åke Borg, Sakari Knuutila, Thoas Fioretos, Wiking Månsson & Mattias Höglund, 2008, I : BMC Cancer. 8, June 30, 183.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. 2009
  25. Identification of proteins involved in neural progenitor cell targeting of gliomas

    Karin Staflin, Thole Zuchner, Gabriella Honeth, Anna Darabi & Cecilia Lundberg, 2009, I : BMC Cancer. 9

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors

    Johanna Tuomela, Maija Valta, Jani Seppanen, Kati Tarkkonen, H. Kalervo Vaananen & Pirkko Härkönen, 2009, I : BMC Cancer. 9

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2010
  28. Cystatin E/M suppresses legumain activity and invasion of human melanoma

    Jon J. Briggs, Mads H. Haugen, Harald T. Johansen, Adam I. Riker, Magnus Abrahamson, Oystein Fodstad, Gunhild M. Maelandsmo & Rigmor Solberg, 2010, I : BMC Cancer. 10

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts

    Johanna Tuomela, Tove J. Gronroos, Maija P. Valta, Jouko Sandholm, Aleksi Schrey, Jani Seppanen, Paivi Marjamaki, Sarita Forsback, Ilpo Kinnunen, Olof Solin, Heikki Minn & Pirkko Härkönen, 2010, I : BMC Cancer. 10

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. HIF1 alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation

    Nastaran Monsef, Maria Soller, Ioannis Panagopoulos & Per-Anders Abrahamsson, 2010, I : BMC Cancer. 10

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.

    Alexander Gaber, Björn Nodin, Kristina Hotakainen, Elise Nilsson, Ulf-Håkan Stenman, Anders Bjartell, Helgi Birgisson & Karin Jirström, 2010, I : BMC Cancer. 10, 1, 498.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study

    Wenjing Zhou, Karin Jirström, Christine Johansson, Rose-Marie Amini, Carl Blomqvist, Olorunsola Agbaje & Fredrik Warnberg, 2010, I : BMC Cancer. 10

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes

    Kari Hemminki, Irene Santi, Marianne Weires, Hauke Thomsen, Jan Sundquist & Justo Lorenzo Bermejo, 2010, I : BMC Cancer. 10

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer

    Donal J. Brennan, Jenny Brändstedt, Elton Rexhepaj, Michael Foley, Fredrik Ponten, Mathias Uhlen, William M. Gallagher, Darran P. O'Connor, Colm O'Herlihy & Karin Jirström, 2010, I : BMC Cancer. 10

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray

    Elin Mollerstrom, Aniko Kovacs, Kristina Lövgren, Szilard Nemes, Ulla Delle, Anna Danielsson, Toshima Parris, Donal J. Brennan, Karin Jirström, Per Karlsson & Khalil Helou, 2010, I : BMC Cancer. 10

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer

    Elton Rexhepaj, Karin Jirström, Darran P. O'Connor, Sallyann L. O'Brien, Göran Landberg, Michael J. Duffy, Donal J. Brennan & William M. Gallagher, 2010, I : BMC Cancer. 10

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. 2011
  38. Cyclin D1, Id1 and EMT in breast cancer

    Nicholas P. Tobin, Andrew H. Sims, Katja L. Lundgren, Sophie Lehn & Göran Landberg, 2011, I : BMC Cancer. 11

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Influence of family size and birth order on risk of cancer: a population-based study

    Melanie Bevier, Marianne Weires, Hauke Thomsen, Jan Sundquist & Kari Hemminki, 2011, I : BMC Cancer. 11

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies

    Quinci Romero, Pär-Ola Bendahl, Marie Klintman, Niklas Loman, Christian Ingvar, Lisa Rydén, Carsten Rose, Dorthe Grabau & Signe Borgquist, 2011, I : BMC Cancer. 11

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene.

    Henna Mattila, Martin Schindler, Jarkko Isotalo, Tarja Ikonen, Mauno Vihinen, Hannu Oja, Teuvo L J Tammela, Tiina Wahlfors & Johanna Schleutker, 2011, I : BMC Cancer. 11, 327.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Prediction of outcome after diagnosis of metachronous contralateral breast cancer.

    Sara Alkner, Pär-Ola Bendahl, Mårten Fernö, Jonas Manjer & Lisa Rydén, 2011, I : BMC Cancer. 11, 114.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study

    Annemieke W. J. Opstal-van Winden, Esmeralda J. M. Krop, Monica Kåredal, Marie-Christine W. Gast, Christian Lindh, Marina Jeppsson, Bo A Jönsson, Diederick E. Grobbee, Petra H. M. Peeters, Jos H. Beijnen, Carla H. van Gils & Roel C. H. Vermeulen, 2011, I : BMC Cancer. 11

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation

    Sandra Sernbo, Elin Gustavsson, Donal J. Brennan, William M. Gallagher, Elton Rexhepaj, Frida Rydnert, Karin Jirström, Carl Borrebaeck & Sara Ek, 2011, I : BMC Cancer. 11

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. 2012
  46. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study

    Anna-Karin Falck, Pär-Ola Bendahl, Christian Ingvar, Jorma Isola, Per-Ebbe Jönsson, Pia Lindblom, Kristina Lövgren, Karin Rennstam, Mårten Fernö & Lisa Rydén, 2012, I : BMC Cancer. 12

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Expanded clinical and experimental use of SOX11-using a monoclonal antibody

    Lena Nordström, Ulrika Andreasson, Mats Jerkeman, Michael Dictor, Carl Borrebaeck & Sara Ek, 2012, I : BMC Cancer. 12, 269

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Identification of BIRC6 as a novel intervention target for neuroblastoma therapy

    Fieke Lamers, Linda Schild, Jan Koster, Frank Speleman, Ingrid Øra, Ellen M. Westerhout, Peter van Sluis, Rogier Versteeg, Huib N. Caron & Jan J. Molenaar, 2012, I : BMC Cancer. 12

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study

    Josef Thaler, Meinolf Karthaus, Laurent Mineur, Richard Greil, Henry Letocha, Ralf Hofheinz, Eva Fernebro, Erick Gamelin, Ana Banos & Claus-Henning Koehne, 2012, I : BMC Cancer. 12, 438

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma

    Lina Y. Dimberg, Anna Dimberg, Karolina Ivarsson, Marten Fryknas, Linda Rickardson, Gerard Tobin, Simon Ekman, Rolf Larsson, Urban Gullberg, Kenneth Nilsson, Fredrik Oberg & Helena Jernberg Wiklund, 2012, I : BMC Cancer. 12

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer

    Anna H Larsson, Marie Fridberg, Alexander Gaber, Björn Nodin, Per Levéen, Göran B Jönsson, Mathias Uhlen, Helgi Birgisson & Karin Jirström, 2012, I : BMC Cancer. 12

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. 2013
  53. Automatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections

    Giuseppe Lippolis, Anders Edsjö, Leszek Helczynski, Anders Bjartell & Niels Christian Overgaard, 2013, I : BMC Cancer. 13, s. 408-418

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3

    Lars Ekblad, Gustaf Lindgren, Emma Persson, Elisabeth Kjellén & Johan Wennerberg, 2013, I : BMC Cancer. 13, 33.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer

    Matias Riihimäki, Hauke Thomsen, Akseli Hemminki, Kristina Sundquist & Kari Hemminki, 2013, I : BMC Cancer. 13

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 Nästa